Graybug Vision Collaborator Dr. Peter Campochiaro Presented at ARVO 2016
May 02, 2016 15:45 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - May 2, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
Graybug Vision Announces $44.5 Million Series B Financing
May 02, 2016 08:00 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - May 2, 2016) - Graybug Vision, a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases including wet...
Ophthalmology Product Company Graybug Vision to Present Data at ARVO 2016
April 25, 2016 08:00 ET
|
Graybug Vision, Inc.
REDWOOD CITY, CA--(Marketwired - Apr 25, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
Ophthalmic Company GrayBug to Present at BIO CEO & Investor Conference on February 8
February 04, 2016 08:00 ET
|
GrayBug
BALTIMORE, MD--(Marketwired - Feb 4, 2016) - GrayBug, Inc., a venture-stage pharmaceutical company developing microparticle controlled release drug delivery technologies for the treatment of ocular...
GrayBug's Jeffrey Cleland to Present at Glaucoma 360 on January 29
January 29, 2016 08:00 ET
|
Graybug
BALTIMORE, MD--(Marketwired - Jan 29, 2016) - GrayBug, Inc., a venture-stage pharmaceutical company developing microparticle controlled release drug delivery technologies for the treatment of...
GrayBug to Present at Biotech Showcase 2016 in San Francisco on January 12
January 07, 2016 08:00 ET
|
GrayBug
BALTIMORE, MD--(Marketwired - Jan 7, 2016) - GrayBug, Inc., a venture-stage pharmaceutical company developing microparticle controlled release drug delivery technologies for the treatment of ocular...
GrayBug Announces Presentation at the OIS@AAO Drug Delivery Company Showcase
November 12, 2015 08:00 ET
|
GrayBug
BALTIMORE, MD--(Marketwired - Nov 12, 2015) - GrayBug, Inc., a venture-stage pharmaceutical company developing microparticle controlled release drug delivery technologies for the treatment of ocular...